Toby Gropen, MD
Neurology · Birmingham, ALNPI 1396707832
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $719 of the $1,063 with a category attached, or 67.6%. Genentech, Inc. accounts for 98.6% of it on its own, with 1 other manufacturer making up the rest. 2022 is the largest year on record at $879, more than ten times the $15 reported in 2019. That places this record below the midpoint for neurology clinicians in AL, where the typical reported total is $2,219.
Across 5 payments — averaging $212.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$1K
- Medtronic$15
Across 26 payments — averaging $5631.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$146K
What the payments were for
- Travel & lodging$71968%
- Food & beverage$34532%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 4 | $1,049 |
| Medtronic | 1 | $15 |
How this compares
$1,063 in reported general payments places this provider in the 40th percentile of 255 neurology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $15,325 |
| Rosuvastatin Calcium | 41 | $1,024 |
| Ezetimibe | 27 | $523 |
| Levetiracetam | 11 | $268 |
| Cilostazol | 17 | $222 |
| Atorvastatin Calcium | 18 | $204 |
Paid to pharmacies, not to this prescriber.
Other neurology in Birmingham
- Diane CounceBirmingham$895K
- Emily RiserBirmingham$231K
- Wesley KingBirmingham$167K
- Jerzy SzaflarskiBirmingham$164K
- Victor SungBirmingham$138K
- Raymond FaughtBirmingham$99K
- David GeldmacherBirmingham$99K
- David StandaertBirmingham$82K
- Richard DiethelmBirmingham$65K
- Mina LobbousBirmingham$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.